Dr. Antony Joseph Charles, MD

Dr. Charles practices at Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital.

Dr. Charles' NPI, 1467435222, was assigned on November 25, 2005. Dr. Charles graduated from Kilpauk Medical College in 1993. Dr. Charles holds Georgia license 88152.

Dr. Charles' primary practice is Northside Hospital Atlanta, at 1000 Johnson Ferry Road, NE, Atlanta, GA 30342 in Fulton County. The practice phone is (404) 851-8000.

Dr. Charles' primary practice is Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital. Dr. Charles is also affiliated with Northeast Georgia Medical Center Gainesville. The medical group on file is UT Internal Medicine - Pellissippi. Dmand AI also links Dr. Charles to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Charles practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Charles' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Charles is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Charles' licenses on file in 6 states: Georgia, Oregon, Tennessee, Florida, North Carolina and New Mexico.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Charles treats.

CMS data shows 6,759 Medicare services from Dr. Charles across 19 procedure codes in 2024, for 306 Medicare patients. Medicare paid $115,575 for them.

CMS counts 306 Medicare patients who saw Dr. Charles in 2024. The largest group is 65 to 74, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Charles' median patient age at 72, with 53% women.

In 2024, Dr. Charles wrote 535 Medicare Part D claims for 136 patients. 86% of them were for generic drugs. CMS names the drug for 359 of them, across 18 drugs with 11 or more claims each, at $27,717 in total drug cost. In 2023, CMS named 623 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Charles for performance year 2024, reported as part of a group. Dr. Charles accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Charles as offering telehealth.

Dmand AI links Dr. Charles to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Male, Prostatic Neoplasms and Breast Neoplasms.

CMS Open Payments shows 1,317 general payments to Dr. Charles from 75 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Bristol-Myers Squibb Company paid the most, $1,727.

Dr. Charles graduated from Kilpauk Medical College in 1993. Dr. Charles is a member of ACP, ASCO and ASH.

Dr. Charles is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.